Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
- PMID: 21627842
- PMCID: PMC3117833
- DOI: 10.1186/1477-5751-10-7
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
Abstract
Background: Histopathological grading of ependymoma has been controversial with respect to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology of 229 intracranial ependymomas from European trial cohorts of infants (2 trials - SFOP/CNS9204) and older children (2 trials - AIEOP/CNS9904) to assess both diagnostic concordance among five neuropathologists and the prognostic utility of histopathological variables, particularly tumor grading.
Results: In phase 1, using WHO criteria and without first discussing any issue related to grading ependymomas, pathologists assessed and independently graded ependymomas from 3 of 4 trial cohorts. Diagnosis of grade II ependymoma was less frequent than grade III, a difference that increased when one cohort (CNS9204) was reassessed in phase 2, during which the pathologists discussed ependymoma grading, jointly reviewed all CNS9204 tumors, and defined a novel grading system based on the WHO classification. In phase 3, repeat independent review of two cohorts (SFOP/CNS9904) using the novel system was associated with a substantial increase in concordance on grading. Extent of tumor resection was significantly associated with progression-free survival (PFS) in SFOP and AIEOP, but not in CNS9204 and CNS9904. Strength of consensus on grade was significantly associated with PFS in only one trial cohort (AIEOP). Consensus on the scoring of individual histopathological features (necrosis, angiogenesis, cell density, and mitotic activity) correlated with PFS in AIEOP, but in no other trial.
Conclusions: We conclude that concordance on grading ependymomas can be improved by using a more prescribed scheme based on the WHO classification. Unfortunately, this appears to have utility in limited clinical settings.
Figures
Similar articles
-
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).Clin Cancer Res. 2012 Apr 1;18(7):2001-11. doi: 10.1158/1078-0432.CCR-11-2489. Epub 2012 Feb 14. Clin Cancer Res. 2012. PMID: 22338015
-
The clinical and prognostic relevance of grading in intracranial ependymomas.Br J Neurosurg. 1997 Oct;11(5):421-8. doi: 10.1080/02688699745925. Br J Neurosurg. 1997. PMID: 9474274
-
Prognostic Factors and Histopathological Features of Pediatric Intracranial Ependymomas: Nationwide Brain Tumor Registry-based Study of Japan.Neurol Med Chir (Tokyo). 2022 Jul 15;62(7):322-327. doi: 10.2176/jns-nmc.2022-0027. Epub 2022 May 10. Neurol Med Chir (Tokyo). 2022. PMID: 35545504 Free PMC article.
-
A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.J Neurosurg Pediatr. 2013 Jun;11(6):673-81. doi: 10.3171/2013.2.PEDS12345. Epub 2013 Mar 29. J Neurosurg Pediatr. 2013. PMID: 23540528 Review.
-
Classification and controversies in pathology of ependymomas.Childs Nerv Syst. 2009 Oct;25(10):1185-93. doi: 10.1007/s00381-008-0804-4. Epub 2009 Feb 11. Childs Nerv Syst. 2009. PMID: 19212775 Review.
Cited by
-
Supratentorial and Infratentorial Ependymoma.Adv Tech Stand Neurosurg. 2024;53:93-118. doi: 10.1007/978-3-031-67077-0_7. Adv Tech Stand Neurosurg. 2024. PMID: 39287805 Review.
-
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement.Acta Neuropathol Commun. 2024 Sep 3;12(1):143. doi: 10.1186/s40478-024-01809-9. Acta Neuropathol Commun. 2024. PMID: 39228008 Free PMC article.
-
Radiotherapy dosing in intracranial ependymoma using the national cancer database.J Neurooncol. 2024 Aug 28. doi: 10.1007/s11060-024-04805-0. Online ahead of print. J Neurooncol. 2024. PMID: 39196482
-
Long-read sequencing for brain tumors.Front Oncol. 2024 Jun 10;14:1395985. doi: 10.3389/fonc.2024.1395985. eCollection 2024. Front Oncol. 2024. PMID: 38915364 Free PMC article. Review.
-
Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning.Nat Med. 2024 Jul;30(7):1952-1961. doi: 10.1038/s41591-024-02995-8. Epub 2024 May 17. Nat Med. 2024. PMID: 38760587
References
-
- Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19:1288–1296. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical